Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5126]
News [14840]
Articles [105]
Editorials [3]
Conferences [245]
elearning [21]
Clinical characteristics and prognostic factors of plasmablastic lymphoma...
Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients ( Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France )
11 Jun 2016
Blinatumomab improves survival of relapsed B-cell leukaemia
Prof Max Topp - University of Würzburg, Würzburg, Germany
Blinatumomab improves survival of relapsed B-cell leukaemia ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
11 Jun 2016
SGN-CD33A combined with HMA therapy produces high remission rates among older...
Dr Amir Fathi - Massachusetts General Hospital, Boston, USA
SGN-CD33A combined with HMA therapy produces high remission rates among older patients with AML ( Dr Amir Fathi - Massachusetts General Hospital, Boston, USA )
11 Jun 2016
Improved survival in adult ALL
Dr Nina Toft - Rigshospitalet, Copenhagen, Denmark
Improved survival in adult ALL ( Dr Nina Toft - Rigshospitalet, Copenhagen, Denmark )
11 Jun 2016
Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia
Dr Charles De Bock - KU Leuven, Leuven, Belgium
Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia ( Dr Charles De Bock - KU Leuven, Leuven, Belgium )
10 Jun 2016
SL401 in patients with rare neoplasm
Prof Naveen Pemmaraju - The University of Texas MD Anderson Cancer Center...
SL401 in patients with rare neoplasm ( Prof Naveen Pemmaraju - The University of Texas MD Anderson Cancer Center, Houston, United States )
10 Jun 2016
RNA regulation of JAK-STAT pathways in CML
Prof Danilo Perrotti - The University of Maryland Baltimore, Baltimore, USA
RNA regulation of JAK-STAT pathways in CML ( Prof Danilo Perrotti - The University of Maryland Baltimore, Baltimore, USA )
10 Jun 2016
Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence
Dr Klaus Metzeler - Ludwig-Maximilians-Universität, Munich, Germany
Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence ( Dr Klaus Metzeler - Ludwig-Maximilians-Universität, Munich, Germany )
10 Jun 2016
Blinatumomab improves survival in ALL patients
Prof Max Topp - University of Würzburg, Würzburg, Germany
Blinatumomab improves survival in ALL patients ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
10 Jun 2016
Evaluation of ibrutinib in treatment of CLL with 17p deletion
Dr Jeffrey Jones - OSU James Cancer Hospital, Columbus, USA
Evaluation of ibrutinib in treatment of CLL with 17p deletion ( Dr Jeffrey Jones - OSU James Cancer Hospital, Columbus, USA )
10 Jun 2016
Nivolumab restores effective anti-tumour response in Hodgkin lymphoma
Dr Anas Younes - Memorial Sloan Kettering Cancer Centre, New York, USA
Nivolumab restores effective anti-tumour response in Hodgkin lymphoma ( Dr Anas Younes - Memorial Sloan Kettering Cancer Centre, New York, USA )
10 Jun 2016
An overview of MCL from EHA 2016
Professor Simon Rule and Professor Steven Le Gouill
An overview of MCL from EHA 2016 ( Professor Simon Rule and Professor Steven Le Gouill )
10 Jun 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation